BRPI0306167B8 - process for obtaining extracts and active fractions of sylvestris casearia and their uses - Google Patents

process for obtaining extracts and active fractions of sylvestris casearia and their uses

Info

Publication number
BRPI0306167B8
BRPI0306167B8 BRPI0306167A BR0306167A BRPI0306167B8 BR PI0306167 B8 BRPI0306167 B8 BR PI0306167B8 BR PI0306167 A BRPI0306167 A BR PI0306167A BR 0306167 A BR0306167 A BR 0306167A BR PI0306167 B8 BRPI0306167 B8 BR PI0306167B8
Authority
BR
Brazil
Prior art keywords
casearia
sylvestris
active fractions
extracts
active
Prior art date
Application number
BRPI0306167A
Other languages
Portuguese (pt)
Other versions
BR0306167A (en
BRPI0306167B1 (en
Inventor
José Cavalheiro Alberto
Gonzaga Dos Santos André
Gomes Tininis Aristeu
Antonio Aboin Sertié Jayme
Gomide Woisky Ricardo
Da Silva Bolzani Vanderlan
Original Assignee
Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp
Univ Estadual Paulista Julio De Mesquita Filho Unesp
Univ De Sao Paulo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp, Univ Estadual Paulista Julio De Mesquita Filho Unesp, Univ De Sao Paulo filed Critical Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp
Priority to BRPI0306167A priority Critical patent/BRPI0306167B8/en
Publication of BR0306167A publication Critical patent/BR0306167A/en
Publication of BRPI0306167B1 publication Critical patent/BRPI0306167B1/en
Publication of BRPI0306167B8 publication Critical patent/BRPI0306167B8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"processo de obtenção de extratos de casearia sylvestris, processos de obtenção de frações ativas, extratos, frações ativas, uso de extratos e frações ativas, composição, unidade de dosagem, método para prevenir, tratar, combater ou suspender distúrbios gastrintestinais, medicamento e princípio ativo". a presente invenção refere-se a uma droga antiulcerogênica, mais particularmente, a uma droga que compreende uma fração ativa da planta casearia sylvestris como componente eficaz. de forma particular a invenção trata de uma droga útil no tratamento de distúrbios do trato gastrintestinal, principalmente no tratamento de úlcera gastroduodenal, sendo que apresenta ação citoprotetora, age tanto em úlceras leves como moderadas e graves e, sendo seletiva, não apresenta ação abortiva."process for obtaining extracts of sylvestris casearia, processes for obtaining active fractions, extracts, active fractions, use of extracts and active fractions, composition, dosage unit, method to prevent, treat, combat or suspend gastrointestinal disorders, medicine and principle active". the present invention relates to an antiulcer drug, more particularly, to a drug comprising an active fraction of the sylvestris casearia plant as an effective component. in particular, the invention deals with a drug useful in the treatment of gastrointestinal tract disorders, mainly in the treatment of gastroduodenal ulcers, as it has a cytoprotective action, acts on both mild and moderate and severe ulcers and, being selective, does not have an abortive action.

BRPI0306167A 2003-12-18 2003-12-18 process for obtaining extracts and active fractions of sylvestris casearia and their uses BRPI0306167B8 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI0306167A BRPI0306167B8 (en) 2003-12-18 2003-12-18 process for obtaining extracts and active fractions of sylvestris casearia and their uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0306167A BRPI0306167B8 (en) 2003-12-18 2003-12-18 process for obtaining extracts and active fractions of sylvestris casearia and their uses

Publications (3)

Publication Number Publication Date
BR0306167A BR0306167A (en) 2005-08-30
BRPI0306167B1 BRPI0306167B1 (en) 2018-07-03
BRPI0306167B8 true BRPI0306167B8 (en) 2021-05-25

Family

ID=34891696

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0306167A BRPI0306167B8 (en) 2003-12-18 2003-12-18 process for obtaining extracts and active fractions of sylvestris casearia and their uses

Country Status (1)

Country Link
BR (1) BRPI0306167B8 (en)

Also Published As

Publication number Publication date
BR0306167A (en) 2005-08-30
BRPI0306167B1 (en) 2018-07-03

Similar Documents

Publication Publication Date Title
IL225192A (en) Combination of dextromethorphan and quinidine for use in the treatment of mental illness, neuropathic pain or brain injury
BRPI0411906A (en) compounds, process for their preparation, pharmaceutical compositions comprising them, method for treating or preventing a disease mediated by activation of the glycogen synthase enzyme, and use of the compounds
PH12013501791B1 (en) Uses of dpp-iv inhibitors
BRPI0502346A (en) cosmetic treatment process for preventing and / or treating sensitive and / or dry skin, use of an effective amount of at least one notably probiotic microorganism and / or one of its fractions and / or one of its metabolites and cosmetic composition and / or dermatological
BRPI0410041A (en) Methods for Sinus Headache Treatment
BRPI0309855B8 (en) Carbamate-substituted pyrazolpyridines, their uses and preparation process, and drugs
Gupta et al. Garlic extract exhibits antiamyloidogenic activity on amyloid‐beta fibrillogenesis: relevance to Alzheimer's disease
AR044007A1 (en) METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE
BRPI0506970A (en) alpha-aminoamide derivatives useful in treating lower urinary tract disorders
WO2005116088A3 (en) Methods and compositions for treating diseases and disorders associated with siglec-8 expressing cells
BRPI0709581A8 (en) bicycloetheroyl compounds as px27 modulators and their use
BRPI0615690B8 (en) heterocyclic hydroxamate compounds, their uses and pharmaceutical composition
EP1935418A4 (en) Composition for relieving subjective symptoms of fatigue
ATE387212T1 (en) COMPOSITION OF ROSEHIP AND FISH OIL TO RELIEF JOINT PAIN AND STIFFNESS
WO2008149802A1 (en) Anti-fatigue agent and oral composition each comprising andrographolide as active ingredient
SE0950392L (en) Composition for the treatment of skin conditions
EP1844779A3 (en) Tergurid/protergurid for treating chronic pain (e.g. migraine)
WO2007023072A3 (en) Use of ambroxol for the treatment of rhinovirus infections
BR9812660A (en) Compositions and methods for treating respiratory disorders
EP1854470B8 (en) Method of treating inflammation disorders using extracts of passion fruit
TW200724147A (en) Cognitive abilities improving agent
WO2004105689A3 (en) Topical composition for the treatment of skin disorders and methods of using the same
BRPI0306167B8 (en) process for obtaining extracts and active fractions of sylvestris casearia and their uses
Madhavan et al. In vitro and in vivo antioxidant activity studies on the roots of Toddalia asiatica (L.) Lam.(Rutaceae)
BR0312568A (en) Gastrointestinal compositions comprising gaba derivatives

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAU

Free format text: TRANSFERIDO PARTE DOS DIREITOS DE: FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAULO - FAPESP

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DA 11A ANUIDADE.

B08G Application fees: restoration [chapter 8.7 patent gazette]
B15G Petition not considered as such [chapter 15.7 patent gazette]

Free format text: NAO CONHECIDA A PETICAO NO 18150002196 DE 13/02/2015, EM VIRTUDE DO DISPOSTO NO ART. 219, INCISO II, DA LPI, O SERVICO NAO PODE SER REALIZADO POR JA HAVER PETICAO (18140021892 DE 15/12/2014) REFERENTE AO MESMO SERVICO (RESTAURACAO) COM DATA ANTERIOR A PETICAO SUPRACITADA.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted
B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/12/2003 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF